2022
DOI: 10.1016/j.bbi.2022.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral and central kynurenine pathway abnormalities in major depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
25
1
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(29 citation statements)
references
References 66 publications
1
25
1
2
Order By: Relevance
“…Picolinic acid is also known to have antiviral effects on HIV and other viruses, such as herpes simplex, 73 which are known to contribute to CNS inflammation in PLHIV. Our data do not support previous findings of lower levels of picolinic acid in depressed patients, 75 including in PLHIV. 39 Altogether, these findings suggest a protective role of tryptophan, plasma metabolites of serotonin, and indoles on psychiatric symptoms in PLHIV, while kynurenine metabolites showed an opposite effect.…”
Section: Discussioncontrasting
confidence: 99%
“…Picolinic acid is also known to have antiviral effects on HIV and other viruses, such as herpes simplex, 73 which are known to contribute to CNS inflammation in PLHIV. Our data do not support previous findings of lower levels of picolinic acid in depressed patients, 75 including in PLHIV. 39 Altogether, these findings suggest a protective role of tryptophan, plasma metabolites of serotonin, and indoles on psychiatric symptoms in PLHIV, while kynurenine metabolites showed an opposite effect.…”
Section: Discussioncontrasting
confidence: 99%
“…The products of tryptophan metabolism via the kynurenine pathway include both quinolinic acid and kynurenic acid. As an agonist of NMDA receptors, QA leads to increased potential neurotoxic metabolites and releases large amounts of glutamate [ 70 ], and KYNA, a potentially neuroprotective compound [ 71 ], that aggravates depression at low levels [ 72 , 73 ]. In addition to affecting excitatory neurotransmission by acting directly on glutamate receptors, QA and KYNA indirectly modulate glutamate function.…”
Section: Discussionmentioning
confidence: 99%
“…Tryptophan is needed to make serotonin, and its conversion into kynurenine may deplete the availability of serotonin in the brain [ 73 ]. Increases in kynurenine and decreases in tryptophan have been observed in patients with MDD episodes [ 74 , 75 ]. The kynurenine to tryptophan ratio was higher in COVID-19 patients than in healthy controls ( n = 394, mean = 0.05, CI = 0.03–0.10 vs. n = 239, mean = 0.03, CI = 0.02–0.03; p < 0.0001), and correlated positively with disease severity [ 76 ], but its role has not yet been investigated in the pathogenesis of post-COVID-19 depression.…”
Section: Neurobiology Of Post-covid-19 Depressive Symptomsmentioning
confidence: 99%